StoneCo Reports Mixed Q1 2026 Results with Deteriorating Credit Quality
summarizeSummary
StoneCo reported Q1 2026 earnings with modest year-over-year growth but sequential declines in key metrics, alongside a significant deterioration in credit portfolio quality.
check_boxKey Events
-
Mixed Financial Performance
Total revenue and income from continuing operations reached R$3,578.0 million, up 6.5% year-over-year but down 4.0% sequentially. Adjusted Net Income was R$549.1 million, increasing 3.5% year-over-year but decreasing 22.3% quarter-over-quarter.
-
Deteriorating Credit Quality
Provisions for expected credit losses surged to R$166.3 million, up 389.2% year-over-year and 51.6% quarter-over-quarter. Non-performing loans (NPL) 15-90 days increased to 4.97% (from 2.61% YoY and 4.43% QoQ), and NPL > 90 days rose to 6.98% (from 4.57% YoY and 5.21% QoQ).
-
Strong Credit Portfolio Growth
The total credit portfolio reached R$3,224.9 million, growing 122.5% year-over-year and 13.7% quarter-over-quarter. Credit revenues contributed R$297.1 million, increasing 186.2% year-over-year and 25.1% sequentially.
-
Shareholder Returns and Capital Management
Adjusted Basic EPS increased 15.4% year-over-year, partly due to R$2.7 billion in share buybacks over the past twelve months. An extraordinary cash dividend of US$2.53 per share (totaling approximately R$3.08 billion) was paid in May, following the Linx sale.
auto_awesomeAnalysis
StoneCo's first quarter 2026 results show a mixed performance with year-over-year revenue and net income growth, but significant sequential declines. The most concerning aspect is the substantial deterioration in credit quality, evidenced by a sharp increase in loan loss provisions and rising non-performing loans (NPLs). While the company benefited from share buybacks and distributed an extraordinary dividend, these credit trends pose a material risk to future profitability and asset quality.
At the time of this filing, STNE was trading at $10.32 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $9.60 to $19.95. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.